Prof. Jean Paul Lellouch, Bar-Ilan University, Israel

Research Area:

Organic chemistry with Nano(bio)technology & Advanced Materials (surface   engineering and bioactivity)

Research Experience:

Based on former Research definitions, one might be focusing on the following current research & Activity developments/progresses:

Novel surface functionalizations based on electro-conductive polymers towards low-/medium density biochips/conductive coatings & inks, chemically modified CNTs towards CNT-SELDI chips for diagnostic applications; polypyrrolyl/polycarbazolyl functional polyCOOH nanorods for sensing applications; chemically modified SiO2, SiC, TiO2, and SnO2 nanoparticles & related nanocomposites for scratch-resistant, superhydrophobic, & antibacterial sol-gel & polymeric surfaces/matrices; bimodal SiO2 nanoparticles for simultaneous FT-IR & fluorescence-based in vitro and in vivo imaging – Bimodal cancer imaging; photoreactive polymeric/non-polymeric nano(micro)particles for surface modification and nano(micro)structuration; aggregation control & surface modifications of magnetite/maghemite NPs using a novel oxidative surface doping by cationic metallic cations - Innovative nanobiotechnology approaches towards (a) gene silencing (siRNA/micro/lncRNA technology) & gene delivery (in vitro/in vivo therapeutic applications), (b) DNA cellular transfection in stem cells, & (c) anti-diabetic NPs design & fabrication; selected QCM sensing resonating crystals/electrodes for early cancer detection using acoustic non-contact methodologies; innovative interfacial chemistries towards mechanically hard semi-conductor transition metal dichalcogenide inorganic nanotubes & fullerene nanoparticles – “Functional nanofillers” field of mechanicallly reinforced polymers & sensors; environmental-safe antibacterial & anti-biofouling hybrid silica (SiO2) and BSA nanoparticles/coatings building on antibacterial Essential Oil (EOs) components; nanoscale drug delivery systems based on novel Human Serum Albumine/recombinant Human Serum Albumine nanoparticles/MRI-enabling composites.